Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 183-189

  Hansel, William ^a   Enright, Fred ^b   Leuschner, Carola ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

Breast cancer; LH CG receptors; Lytic peptide; Metastases

Indexed keywords

AMINO ACID DERIVATIVE; CHORIONIC GONADOTROPIN; GONADORELIN DERIVATIVE; HECATE BETA CHORIONIC GONADOTROPIN; HYDROLASE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; PHOR14 BETA CHORIONIC GONADOTROPIN; PHOR21 BETA CHORIONIC GONADOTROPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CHAIN; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CELL DEATH; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GONADOTROPIN-RELEASING HORMONE; LUCIFERASES; LUNG; LYMPH NODES; MELITTEN; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PEPTIDES; SPINAL CORD; TUMOR BURDEN;

EID: 33751242027     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.12.056     Document Type: Article

References (36)

1. Al-Hader A., Lei Z.M., and Rao C.V. Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. Biol. Reprod. 56 (1997) 501-507
2. Bodek G., Rahman N.A., Zaleska M., Soliymani R., Lankinen H., Hansel W., Huhtaniemi I., and Ziecik A.J. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. Breast Cancer Res. Treat. 79 (2003) 1-10
3. Bodek G., Kowalczyk A., Waclawik A., Huhtaniemi I., and Ziecik A.J. Targeted ablation of prostate carcinoma cells through LH receptor using hecate-CG{beta} conjugate: functional characteristic and molecular mechanism of cell death pathway. Exp. Biol. Med. (Maywood) 230 (2005) 421-428
4. Bodek G., Vierre S., Rivero-Muller, Huhtaniemi I., Ziecik A.J., and Rahman N.A. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a Hecate-chorionic gonadotropin beta conjugate in transgenic mice. Neoplasia 7 (2005) 497-508
5. Gawronska B., Leuschner C., Enright F.M., and Hansel W. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecol. Oncol. 85 (2002) 45-52
6. Grasso P., Rozhavskaya M., and Reichert Jr. L.E. A synthetic peptide corresponding to amino acid residues 34 to 37 of human follicle-stimulating hormone beta-subunit accelerates the onset of puberty in male and female mice. Endocrinology 138 (1997) 4215-4219
7. Hansel W., Leuschner C., Gawronska B., and Enright F. Targeted destruction of prostate cancer cells and xenografts by lytic peptide-beta LH conjugates. Reprod. Biol. 1 (2001) 20-32
8. Huang Z.H., Lei Z.M., and Rao C.V. Immortalized anterior pituitary alpha T3 gonadotropes contain functional luteinizing hormone/human chorionic gonadotropin receptors. Mol. Cell. Endocrinol. 114 (1995) 217-222
9. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 53 (2003) 5-26
10. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 55 (2005) 10-30
11. Konishi I., Koshiyama M., Mandai M., Kuroda H., Yamamoto S., Nanbu K., Komatsu T., Matsushita K., Rao C.V., and Mori T. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol. Oncol. 65 (1997) 273-280
12. Kornyei J.L., Lei Z.M., and Rao C.V. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol. Reprod. 49 (1993) 1149-1157
13. Kuroda H., Konishi I., Nanbu K., Mandai M., Matsushita K., Hamid A., Yura Y., Rao C.V., and Mori T. Ovarian cancer in infertile women during or after ovulation-induction therapy; expression of LH/hCG receptors and sex steroid receptors. Int. J. Gynecol. Cancer 7 (1997) 451-457
14. Lei Z.M., and Rao C.V. Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons. Mol. Endocrinol. 8 (1994) 1111-1121
15. Lei Z.M., Toth P., Rao C.V., and Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J. Clin. Endocrinol. Metab. 77 (1993) 863-872
16. Leuschner C., and Hansel W. Membrane disrupting lytic peptides for cancer treatments. Curr. Pharm. Des. 10 (2004) 2299-2310
17. Leuschner C., and Hansel W. Targeting breast and prostate cancers through their hormone receptors. Biol. Reprod. 73 (2005) 860-865
18. Leuschner C., Enright F.M., Melrose P.A., and Hansel W. Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors. Prostate 46 (2001) 116-125
19. Leuschner C., Enright F., Gawronska B., and Hansel W. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Res. Treat. 78s (2003) 17-27
20. Li X., Lei Z.M., and Rao C.V. Human chorionic gonadotropin down-regulates the expression of gonadotropin-releasing hormone receptor gene in GT1-7 neurons. Endocrinology 137 (1996) 899-904
21. Lin J., Lojun S., Lei Z.M., Wu W.X., Peiner S.C., and Rao C.V. Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene. Mol. Cell. Endocrinol. 111 (1995) R13-R17
22. Lojun S., Bao S., Lei Z.M., and Rao C.V. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol. Reprod. 57 (1997) 1202-1210
23. Meduri G., Charnaux N., Loosfelt H., Jolivet A., Spyratos F., Brailly S., and Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res. 57 (1997) 857-864
24. Morbeck D.E., Roche P.C., Keutmann H.T., and McCormick D.J. A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG). Mol. Cell. Endocrinol. 97 (1993) 173-781
25. Pabon J.E., Li X., Lei Z.M., Sanfilippo J.S., Yussman M.A., and Rao C.V. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81 (1996) 2397-2400
26. Pabon J.E., Bird J.S., Li X., Huang Z.H., Lei Z.M., Sanfilippo J.S., Yussman M.A., and Rao C.V. Human skin contains luteinizing hormone/chorionic gonadotropin receptors. J. Clin. Endocrinol. Metab. 81 (1996) 2738-2741
27. Pantel K., and Otte M. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumor cells. Semin. Cancer Biol. 11 (2001) 327-337
28. Rao C.V. The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in non-gonadal tissues. J. Physiol. Pharmacol. 47 (1996) 41-53
29. Rao C.V. Immunocytochemical localization of gonadotropin and gonadal steroid receptors in human pineal glands. J. Clin. Endocrinol. Metab. 82 (1997) 2756-2757
30. Rubio N., Villacampa M.M., and Blanco J. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Lab. Invest. 78 (1998) 1315-1325
31. Rubio N., Villacampa M.M., El Hilali N., and Blanco J. Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker. Prostate 44 (2000) 133-143
32. Tao Y.X., Bao S., Ackermann D.M., Lei Z.M., and Rao C.V. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans. Biol. Reprod. 56 (1997) 67-72
33. Tao Y.X., Heit M., Lei Z.M., and Rao C.V. The urinary bladder of a woman is a novel site of luteinizing hormone-human chorionic gonadotropin receptor gene expression. Am. J. Obstet. Gynecol. 179 (1998) 1026-1031
34. Toth P., Lukacs H., Gimes G., Sebestyen A., Pasztor N., Paulin F., and Rao C.V. Clinical importance of vascular LH/hCG receptors-a review. Reprod. Biol. 1 (2001) 5-11
35. Walther H.E. Simultaneous occurrence of malignant tumors and systemic diseases. Radiol. Clin. 20 (1951) 405-412
36. Zaleska M., Waclawik A., Bodek G., Zezula-Szpyra A., Li X., Janowski T., Hansel W.H., Rahman N.A., and Ziecik A.J. Growth repression in diethylstilbestrol/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate. Exp. Biol. Med. (Maywood) 229 (2004) 335-344